Wealthspire Advisors LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 29.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,486 shares of the financial services provider’s stock after purchasing an additional 3,933 shares during the quarter. Wealthspire Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,045,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the stock. Hoey Investments Inc. acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $25,000. Phillips Financial Management LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $32,000. Northwest Investment Counselors LLC boosted its position in shares of iShares Biotechnology ETF by 196.9% during the 3rd quarter. Northwest Investment Counselors LLC now owns 377 shares of the financial services provider’s stock worth $44,000 after acquiring an additional 250 shares in the last quarter. Bessemer Group Inc. increased its holdings in shares of iShares Biotechnology ETF by 66.7% in the 3rd quarter. Bessemer Group Inc. now owns 500 shares of the financial services provider’s stock valued at $58,000 after acquiring an additional 200 shares during the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $75,000. Institutional investors and hedge funds own 58.02% of the company’s stock.
iShares Biotechnology ETF Stock Performance
IBB stock opened at $126.41 on Monday. The business has a 50 day moving average price of $133.40 and a 200 day moving average price of $129.12. iShares Biotechnology ETF has a fifty-two week low of $104.29 and a fifty-two week high of $138.74.
iShares Biotechnology ETF Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, December 19th. Stockholders of record on Wednesday, December 14th were given a dividend of $0.101 per share. This represents a $0.40 annualized dividend and a dividend yield of 0.32%. The ex-dividend date of this dividend was Tuesday, December 13th. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.03.
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.